MDxHealth2018-09-26T18:27:52+00:00

MDxHealth

MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer.  The increased adoption of our ConfirmMDx® for Prostate Cancer testing solution within the U.S. urology community has established MDxHealth as a market leader in the important and growing field of cancer epigenetics.

MDxHealth is a front runner in epigenetic research with a proven track record to identify, develop, validate and deliver molecular diagnostic assays. Leveraging our patented methylation specific PCR technology (MSP) and proprietary portfolio of genes, we have built a robust portfolio of biomarkers for diagnostic, prognostic and predictive molecular assays for prostate, colorectal, lung, bladder and brain cancers, among many others. In addition, MDxHealth has numerous proprietary biomarkers for other solid cancer types ready for development.

Want to know more? Click here!

Kadans Community

Weten of Kadans, of iemand in de Kadans Community, zoals een van de Kadans huurders of partners u kan helpen of inspireren? Wij verbinden graag!

CONTACT